Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Uterine Serous Carcinoma
100%
Clinical Trials
16%
Clinical Efficacy
16%
Advanced Treatment
16%
Clinical Practice Guidelines
16%
Molecular Targets
16%
Targeted Therapy
16%
Endometrial Cancer
16%
Radiotherapy
16%
Trastuzumab
16%
Clinical Management
16%
Genomic Studies
16%
HER2-positive
16%
Systemic Chemotherapy
16%
Recurrent Disease
16%
Cancer Mortality
16%
Novel Targeted Therapy
16%
Expert Opinion
16%
Her2neu
16%
Treatment Recommendations
16%
Tumor Samples
16%
Lymphadenectomy
16%
Surgical Staging
16%
PubMed Database
16%
Uterine Cancer
16%
FBXW7
16%
Distant Recurrence
16%
CCNE1
16%
PIK3C3
16%
Taxane Chemotherapy
16%
Area Cover
16%
Omentectomy
16%
Carboplatin/paclitaxel
16%
Clinical Safety
16%
Medicine and Dentistry
Uterine Serous Carcinoma
100%
Targeted Therapy
33%
Recurrent Disease
33%
Uterine Cancer
33%
Chemotherapy
33%
Clinical Trial
16%
Neoplasm
16%
Carboplatin
16%
Clinical Management
16%
Retroperitoneal Lymph Node Dissection
16%
Omentectomy
16%
Paclitaxel
16%
Protein Kinase B
16%
Trastuzumab
16%
Radiation Therapy
16%
Genetics
16%
Platinum
16%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinoma
100%
Chemotherapy Regimens
33%
Recurrent Disease
33%
Clinical Trial
16%
Molecular Target
16%
Paclitaxel
16%
Endometrium Cancer
16%
Uterus Cancer
16%
Neoplasm
16%
Protein Kinase B
16%
Carboplatin
16%
Trastuzumab
16%
Taxane
16%
Platinum
16%